Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2022-07-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
关于2022年6月份生猪销售简报
Regulatory Filings Classification · 95% confidence The document is a sales brief for June 2022 from Tian Kang Biological Co., Ltd., detailing sales volume and revenue of live pigs, with explanations and risk warnings. It is a short announcement (908 characters) providing interim sales data but not a comprehensive financial report or audited financial statements. It explicitly states the data is unaudited and for investor reference only. There is no indication this is a full interim or quarterly report, nor an annual report. It is a periodic sales update, not a full financial report or earnings release. Given the short length and nature, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement of sales data without full financial statements or detailed analysis.
2022-07-08 Chinese
关于员工持股计划第二次持有人会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the resolutions passed at the second meeting of holders of an employee stock ownership plan. It details voting results on liquidation and authorization matters related to the employee stock ownership plan. The content is about decisions made in a specific meeting and the announcement of those decisions, not a full report or financial statement. The document length is short (1161 characters) and it is an announcement of meeting resolutions rather than the meeting materials themselves or a detailed report. Therefore, it fits best under the category of Regulatory Filings (RNS) as it is a general regulatory announcement about corporate governance matters related to employee stock plans.
2022-07-01 Chinese
2022年第二季度可转换公司债券转股情况的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the convertible bonds (可转换公司债券) of Tian Kang Bio Co., Ltd. It details the bond issuance, conversion prices, adjustments, and the changes in shareholding due to bond conversions during the second quarter of 2022. The document includes specific bond codes, stock codes, conversion prices, and shareholding changes. It is a formal disclosure of bond conversion and shareholding changes rather than a financial report or earnings release. The document length is 2547 characters, which is relatively short and focused on a specific capital market event. This fits the category of Capital/Financing Update (CAP), as it updates on convertible bond conversions and related share capital changes.
2022-07-01 Chinese
关于天康转债跟踪评级结果的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the tracking credit rating result of a convertible bond issued by the company. It references regulatory rules related to bond issuance and trading, and mentions a credit rating report issued by a rating agency. The document is short (604 characters) and primarily serves to disclose the rating result and direct readers to the full rating report on an external website. It does not contain detailed financial statements or comprehensive financial data. Therefore, it is an update related to the company's financing activities, specifically about bond credit rating, which fits best under Capital/Financing Update (CAP).
2022-06-24 Chinese
天康生物股份有限公司公开发行可转换公司债券2022年跟踪评级报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2022 Tracking Rating Report" for convertible bonds issued by Tian Kang Biological Co., Ltd. It contains detailed credit rating information, financial data, industry analysis, and macroeconomic context. The content focuses on credit rating evaluation, financial performance, and risk factors related to the company's bonds. It is a comprehensive credit rating report rather than a general annual or quarterly financial report. It is not an announcement or a brief summary but a full report with substantive financial and credit analysis. Therefore, it fits best into the category of Audit Report / Information (AR), which includes standalone audit reports and credit rating reports related to financial instruments, excluding full annual reports or earnings releases. Q1 2022
2022-06-24 Chinese
关于非公开发行限售股份上市流通的提示性公告
Share Issue/Capital Change Classification · 100% confidence The document is a public announcement regarding the lifting of restrictions on previously non-publicly issued shares, allowing these shares to be listed and traded on the stock exchange. It details the number of shares becoming tradable, the shareholders involved, lock-up periods, and compliance with regulatory approvals. There is no financial statement or detailed financial analysis present, nor is it a report like an annual or interim report. The document is an official notice about share capital changes related to restricted shares becoming freely tradable. This fits the category of Share Issue/Capital Change announcements, as it concerns changes in share capital structure and listing status of shares.
2022-06-22 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.